Metabolic surgery and intestinal gene expression: Digestive tract and diabetes evolution considerations

World Journal of Gastroenterology

Volumn 21, Issue 22, 2015, Pages 6990-6998

  Da Silva Rodrigues, Marcos Ricardo ^a   Santo, Marco Aurelio ^a   Favero, Giovani Marino ^a   Vieira, Elaine Cristina ^a   Artoni, Roberto Ferreira ^a   Nogaroto, Viviane ^a   De Moura, Egberto Gaspar ^a   Lisboa, Patricia ^a   Milleo, Fabio Quirillo ^a  

^a STATE UNIVERSITY OF PONTA GROSSA   (Brazil)

Author keywords

Bariatric surgery; Diabetes mellitus; Gene expression; Hyperglycemia; Hyperplasia; Intestine

Indexed keywords

ANTIDIABETIC AGENT; CHOLESTEROL; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HEMOGLOBIN A1C; INCRETIN; LIPID; TRIACYLGLYCEROL; INSULIN; ORAL ANTIDIABETIC AGENT; TRANSFORMING GROWTH FACTOR; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; PROTEIN P53; TP53 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; BLOOD SAMPLING; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DIET RESTRICTION; DRUG WITHDRAWAL; DUODENUM MUCOSA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; FOOD INTAKE; GENE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HORMONE RELEASE; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; ILEUM MUCOSA; LIPID ANALYSIS; LIPID METABOLISM; MALE; MEAL; METABOLIC PARAMETERS; METABOLIC STABILITY; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL VALUE; OBSERVATIONAL STUDY; P53 GENE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SLEEVE GASTRECTOMY; SLEEVE GASTRECTOMY WITH TRANSIT BIPARTITION; SURGICAL PATIENT; TRANSFORMING GROWTH FACTOR BETA GENE; TREATMENT WITHDRAWAL; TRIACYLGLYCEROL BLOOD LEVEL; CALORIC INTAKE; CHRONIC DISEASE; DIABETIC OBESITY; DISEASE COURSE; GENE LOCATION; HEMOGLOBIN DETERMINATION; OUTCOME ASSESSMENT; QUANTITATIVE ANALYSIS; REFERENCE VALUE; TREATMENT RESPONSE; TUMOR GROWTH FACTOR BETA GENE; TUMOR SUPPRESSOR GENE; BIOPSY; BLOOD; CELL PROLIFERATION; COMPLICATION; DIABETES MELLITUS, TYPE 2; DUODENUM; GASTRECTOMY; GENE EXPRESSION REGULATION; GENETICS; ILEUM; INTESTINE MUCOSA; METABOLISM; OBESITY; PATHOLOGY; POSTPRANDIAL STATE; SECRETION (PROCESS); TIME FACTOR; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; BARIATRIC SURGERY; BIOMARKERS; BIOPSY; BLOOD GLUCOSE; BODY MASS INDEX; CELL PROLIFERATION; DIABETES MELLITUS, TYPE 2; DUODENUM; FASTING; FEMALE; GASTRECTOMY; GASTRIC INHIBITORY POLYPEPTIDE; GENE EXPRESSION REGULATION; GLUCAGON-LIKE PEPTIDE 1; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; ILEUM; INTESTINAL MUCOSA; MALE; MIDDLE AGED; OBESITY; POSTPRANDIAL PERIOD; REMISSION INDUCTION; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEIN P53; WEIGHT LOSS;

EID: 84930858697     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i22.6990     Document Type: Article

References (47)

1. Ye C, Li X, Wang Y, Zhang Y, Cai M, Zhu B, Mu P, Xia X, Zhao Y, Weng J, Gao X, Wen X. Diabetes causes multiple genetic alterations and downregulates expression of DNA repair genes in the prostate. Lab Invest 2011; 91: 1363-1374 [PMID: 21647090 DOI: 10.1038/labinvest.2011.87]
2. Hong S, Lee HJ, Kim SJ, Hahm KB. Connection between inflammation and carcinogenesis in gastrointestinal tract: focus on TGF-beta signaling. World J Gastroenterol 2010; 16: 2080-2093 [PMID: 20440848 DOI: 10.3748/wjg.v16.i17.2080]
3. Li L, Li J, Rao JN, Li M, Bass BL, Wang JY. Inhibition of polyamine synthesis induces p53 gene expression but not apoptosis. Am J Physiol 1999; 276: C946-C954 [PMID: 10199827]
4. Li L, Rao JN, Guo X, Liu L, Santora R, Bass BL, Wang JY. Polyamine depletion stabilizes p53 resulting in inhibition of normal intestinal epithelial cell proliferation. Am J Physiol Cell Physiol 2001; 281: C941-C953 [PMID: 11502571]
5. Liu L, Santora R, Rao JN, Guo X, Zou T, Zhang HM, Turner DJ, Wang JY. Activation of TGF-beta-Smad signaling pathway following polyamine depletion in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 2003; 285: G1056-G1067 [PMID: 12855402 DOI: 10.1152/ajpgi.00151.2003]
6. Schedl HP, Wilson HD. Effects of diabetes on intestinal growth in the rat. J Exp Zool 1971; 176: 487-495 [PMID: 5569235 DOI: 10.1002/jez.1401760410]
7. Fujita Y, Kojima H, Hidaka H, Fujimiya M, Kashiwagi A, Kikkawa R. Increased intestinal glucose absorption and postprandial hyperglycaemia at the early step of glucose intolerance in Otsuka Long-Evans Tokushima Fatty rats. Diabetologia 1998; 41: 1459-1466 [PMID: 9867213 DOI: 10.1007/s001250051092]
8. Noda T, Iwakiri R, Fujimoto K, Yoshida T, Utsumi H, Sakata H, Hisatomi A, Aw TY. Suppression of apoptosis is responsible for increased thickness of intestinal mucosa in streptozotocin-induced diabetic rats. Metabolism 2001; 50: 259-264 [PMID: 11230775 DOI: 10.1053/meta.2001.21030]
9. Adachi T, Mori C, Sakurai K, Shihara N, Tsuda K, Yasuda K. Morphological changes and increased sucrase and isomaltase activity in small intestines of insulin-deficient and type 2 diabetic rats. Endocr J 2003; 50: 271-279 [PMID: 12940455 DOI: 10.1507/ endocrj.50.271]
10. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH. The natural history of impaired glucose tolerance in the Pima Indians. N Engl J Med 1988; 319: 1500-1506 [PMID: 3054559 DOI: 10.1056/NEJM198812083192302]
11. Osborne DL, Payne SC, Russ RD, Tobin B. Comparison of therapeutic regimens in the amelioration of alterations in rat gastrointestinal mucosal DNA, RNA and protein induced by streptozotocin diabetes mellitus. Life Sci 2000; 66: 2405-2417 [PMID: 10864102]
12. Verdam FJ, Greve JW, Roosta S, van Eijk H, Bouvy N, Buurman WA, Rensen SS. Small intestinal alterations in severely obese hyperglycemic subjects. J Clin Endocrinol Metab 2011; 96: E379-E383 [PMID: 21084402 DOI: 10.1210/jc.2010-1333]
13. Santoro S, Castro LC, Velhote MC, Malzoni CE, Klajner S, Castro LP, Lacombe A, Santo M.A. Sleeve gastrectomy with transit bipartition: a potent intervention for metabolic syndrome and obesity. Ann Surg 2012; 256: 104-110 [PMID: 22609843 DOI: 10.1097/SLA.0b013e31825370c0]
14. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012; 35 Suppl 1: S64-S71 [PMID: 22187472 DOI: 10.2337/dc12-s064]
15. Christou NV, Sampalis JS, Liberman M, Look D, Auger S, McLean AP, MacLean LD. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 2004; 240: 416-423; discussion 423-424 [PMID: 15319713 DOI: 10.1097/01.sla.0000137343.63376.19]
16. Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, Thomas S, Abood B, Nissen SE, Bhatt DL. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012; 366: 1567-1576 [PMID: 22449319 DOI: 10.1056/NEJMoa1200225]
17. Sasaki A, Wakabayashi G, Yonei Y. Current status of bariatric surgery in Japan and effectiveness in obesity and diabetes. J Gastroenterol 2014; 49: 57-63 [PMID: 23595611 DOI: 10.1007/ s00535-013-0802-5]
18. Pok EH, Lee WJ. Gastrointestinal metabolic surgery for the treatment of type 2 diabetes mellitus. World J Gastroenterol 2014; 20: 14315-14328 [PMID: 25339819 DOI: 10.3748/wjg.v20. i39.14315]
19. Rubino F, Gagner M, Gentileschi P, Kini S, Fukuyama S, Feng J, Diamond E. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucosemetabolism. Ann Surg 2004; 240: 236-242 [PMID: 15273546 DOI: 10.1097/01.sla.0000133117.12646.48]
20. Liu S, Zhang G, Wang L, Sun D, Chen W, Yan Z, Sun Y, Hu S. The entire small intestine mediates the changes in glucose homeostasis after intestinal surgery in Goto-Kakizaki rats. Ann Surg 2012; 256: 1049-1058 [PMID: 23001083 DOI: 10.1097/ SLA.0b013e31826c3866]
21. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009; 122: 248-256.e5 [PMID: 19272486 DOI: 10.1016/ j.amjmed.2008.09.041]
22. Kaul A, Sharma J. Impact of bariatric surgery on comorbidities. Surg Clin North Am 2011; 91: 1295-312, ix [PMID: 22054155 DOI: 10.1016/j.suc.2011.08.003]
23. Donath MY, Halban PA. Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications. Diabetologia 2004; 47: 581-589 [PMID: 14767595 DOI: 10.1007/ s00125-004-1336-4]
24. Poitout V, Robertson RP. Minireview: Secondary beta-cell failure in type 2 diabetes-a convergence of glucotoxicity and lipotoxicity. Endocrinology 2002; 143: 339-342 [PMID: 11796484 DOI: 10.1210/endo.143.2.8623]
25. Nolan CJ, Damm P, Prentki M. Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet 2011; 378: 169-181 [PMID: 21705072 DOI: 10.1016/ S0140-6736(11)60614-4]
26. Bradley D, Magkos F, Klein S. Effects of bariatric surgery on glucose homeostasis and type 2 diabetes. Gastroenterology 2012; 143: 897-912 [PMID: 22885332 DOI: 10.1053/j.gastro.2012.07.114]
27. Vilsbøll T, Krarup T, Deacon CF, Madsbad S, Holst JJ. Reduced postprandial concentrations of intact biologically active glucagonlike peptide 1 in type 2 diabetic patients. Diabetes 2001; 50: 609-613 [PMID: 11246881 DOI: 10.2337/diabetes.50.3.609]
28. Schirra J, Katschinski M, Weidmann C, Schäfer T, Wank U, Arnold R, Göke B. Gastric emptying and release of incretin hormones after glucose ingestion in humans. J Clin Invest 1996; 97: 92-103 [PMID: 8550855 DOI: 10.1172/JCI118411]
29. de Moura EG, Orso IR, Martins BC, Lopes GS, de Oliveira SL, Galvão-Neto Mdos P, Mancini MC, Santo MA, Sakai P, Ramos AC, Garrido-Júnior AB, Halpern A, Cecconello I. Improvement of insulin resistance and reduction of cardiovascular risk among obese patients with type 2 diabetes with the duodenojejunal bypass liner. Obes Surg 2011; 21: 941-947 [PMID: 21442376 DOI: 10.1007/ s11695-011-0387-0]
30. Escalona A, Pimentel F, Sharp A, Becerra P, Slako M, Turiel D, Muñoz R, Bambs C, Guzmán S, Ibáñez L, Gersin K. Weight loss and metabolic improvement in morbidly obese subjects implanted for 1 year with an endoscopic duodenal-jejunal bypass liner. Ann Surg 2012; 255: 1080-1085 [PMID: 22534421 DOI: 10.1097/ SLA.0b013e31825498c4]
31. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trial. Lancet 2002; 359: 2072-2077 [PMID: 12086760]
32. Cummings D.E. Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery. Int J Obes (Lond) 2009; 33 Suppl 1: S33-S40 [PMID: 19363506 DOI: 10.1038/ijo.2009.15]
33. DePaula AL, Macedo AL, Schraibman V, Mota BR, Vencio S. Hormonal evaluation following laparoscopic treatment of type 2 diabetes mellitus patients with BMI 20-34. Surg Endosc 2009; 23: 1724-1732 [PMID: 18830747 DOI: 10.1007/s00464-008-0168-6]
34. Braghetto I, Davanzo C, Korn O, Csendes A, Valladares H, Herrera E, Gonzalez P, Papapietro K. Scintigraphic evaluation of gastric emptying in obese patients submitted to sleeve gastrectomy compared to normal subjects. Obes Surg 2009; 11: 1515-1521 [DOI: 10.1007/s11695-009-9954-z]
35. Theodorakis MJ, Carlson O, Muller DC, Egan JM. Elevated plasma glucose-dependent insulinotropic polypeptide associates with hyperinsulinemia in impaired glucose tolerance. Diabetes Care 2004; 27: 1692-1698 [PMID: 15220248]
36. Højberg PV, Vilsbøll T, Rabøl R, Knop FK, Bache M, Krarup T, Holst JJ, Madsbad S. Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes. Diabetologia 2009; 52: 199-207 [PMID: 19037628 DOI: 10.1007/s00125-008-1195-5]
37. Rao RS, Kini S. GIP and bariatric surgery. Obes Surg 2011; 21: 244-252 [PMID: 21082290 DOI: 10.1007/s11695-010-0305-x]
38. Laferrère B, Teixeira J, McGinty J, Tran H, Egger JR, Colarusso A, Kovack B, Bawa B, Koshy N, Lee H, Yapp K, Olivan B. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab 2008; 93: 2479-2485 [PMID: 18430778 DOI: 10.1210/jc.2007-2851]
39. Mumphrey MB, Patterson LM, Zheng H, Berthoud HR. Rouxen-Y gastric bypass surgery increases number but not density of CCK-, GLP-1-, 5-HT-, and neurotensin-expressing enteroendocrine cells in rats. Neurogastroenterol Motil 2013; 25: e70-e79 [PMID: 23095091 DOI: 10.1111/nmo.12034]
40. Gupta D, Krueger CB, Lastra G. Over-nutrition, obesity and insulin resistance in the development of β-cell dysfunction. Curr Diabetes Rev 2012; 8: 76-83 [PMID: 22229253]
41. Gross LS, Li L, Ford ES, Liu S. Increased consumption of refined carbohydrates and the epidemic of type 2 diabetes in the United States: an ecologic assessment. Am J Clin Nutr 2004; 79: 774-779 [PMID: 15113714]
42. Weser E, Babbitt J, Vandeventer A. Relationship between enteral glucose load and adaptive mucosal growth in the small bowel. Dig Dis Sci 1985; 30: 675-681 [PMID: 3924534]
43. Alvarado-Vásquez N, Zapata E, Alcázar-Leyva S, Massó F, Montaño LF. Reduced NO synthesis and eNOS mRNA expression in endothelial cells from newborns with a strong family history of type 2 diabetes. Diabetes Metab Res Rev 2007; 23: 559-566 [PMID: 17385193]
44. Burgdorf KS, Grarup N, Justesen JM, Harder MN, Witte DR, Jørgensen T, Sandbæk A, Lauritzen T, Madsbad S, Hansen T, Pedersen O. Studies of the association of Arg72Pro of tumor suppressor protein p53 with type 2 diabetes in a combined analysis of 55,521 Europeans. PLoS One 2011; 6: e15813 [PMID: 21283750 DOI: 10.1371/journal.pone.0015813]
45. Schwartzenberg-Bar-Yoseph F, Armoni M, Karnieli E. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res 2004; 64: 2627-2633 [PMID: 15059920]
46. Vousden KH, Ryan KM. p53 and metabolism. Nat Rev Cancer 2009; 9: 691-700 [PMID: 19759539 DOI: 10.1038/nrc2715]
47. Saeidi N, Meoli L, Nestoridi E, Gupta NK, Kvas S, Kucharczyk J, Bonab AA, Fischman AJ, Yarmush ML, Stylopoulos N. Reprogramming of intestinal glucose metabolism and glycemic control in rats after gastric bypass. Science 2013; 341: 406-410 [PMID: 23888041 DOI: 10.1126/science.1235103]